Quarterly report · Q2
8182.TEDINET S100PJMJ
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥117.9bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥123.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating revenue1 |
| Revenue | ¥5.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating revenue2 |
| Revenue | ¥240.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥123.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥129.0bn | 2021-04-01 → 2021-09-30 | Cons. | Operating revenue1 |
| Revenue | ¥5.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating revenue2 |
| Operating income | ¥230m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥343m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥3.9bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥321m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.8bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥106m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥139m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥98.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥98.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥96.3bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥41.4bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥41.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥57.2bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥56.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥56.8bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥19.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.1bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥625m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥2.3 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.7 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.77 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.65 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.32 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 56.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.8% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥4.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥4.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | ¥11m |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥21.7bn |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥21.7bn |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥297m |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.8bn |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥337m |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥160m |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥95.8bn |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥95.8bn |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥1m |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥238m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥122.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥117.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥219m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥4.1bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥25m |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥21.7bn |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥21.7bn |
| jpcrp040300-q2r_E03064-000Drugstore Operationsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥412m |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥339m |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E03064-000Retail Support Operationsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥186m |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥101.7bn |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥101.7bn |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥1m |
| jpcrp040300-q2r_E03064-000Supermarket Operationsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥127.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥123.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 551
| Item | Context | Value | Unit |
|---|---|---|---|
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |